Lung cancer marker anti-ACTR3 autoantibody and applications thereof
A technology of autoantibodies and markers, applied in the field of biomedical detection, can solve the problems of unsatisfactory tumor markers, and achieve the effect of low cost, high accuracy and simple operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] 1. Collection of serum samples
[0030] A total of 1379 subjects were included in this study, which were divided into test group and verification group. The serum of 184 lung cancer patients included in the test group came from lung cancer patients in the First Affiliated Hospital of Zhengzhou University from 2016 to 2017. The sera of 446 lung cancer patients included in the verification group were from lung cancer patients who were treated in the First Affiliated Hospital of Zhengzhou University from 2013 to 2014. All cases were confirmed by histopathology without any operation, radiotherapy and chemotherapy. The 184 normal controls in the test group and the 446 normal controls in the verification group were all from healthy persons who underwent physical examination in the First Affiliated Hospital of Zhengzhou University. They were matched with cases according to age and sex, and they were free from tumor-related diseases and respiratory diseases. Sera from 119 cas...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com